INTERMITTENT 2-HOUR INTRAVENOUS INFUSIONS OF 2-CHLORODEOXYADENOSINE IN THE TREATMENT OF 110 PATIENTS WITH REFRACTORY OR PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
T. Robak et al., INTERMITTENT 2-HOUR INTRAVENOUS INFUSIONS OF 2-CHLORODEOXYADENOSINE IN THE TREATMENT OF 110 PATIENTS WITH REFRACTORY OR PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 22(5-6), 1996, pp. 509-514
The purpose of our study was to determine the effectiveness of 2-CdA i
n 2-hour intravenous infusions in the treatment of B-CLL. One hundred
and ten patients with B-CLL received 1 to 10 courses of 2-CdA (median
2.5) at a dosage of 0.12 mg/kg daily for 5 consecutive days. Eighteen
of them were untreated and 92 relapsed or became refractory to previou
s therapeutic modalities. Complete remission (CR) was achieved in 8 (7
.3%) and partial remission (PR) in 35 patients (31.8%) giving an overa
ll response rate of 39.1%. In 3 patients, cross-resistance to fludarab
ine was noticed. Toxic effects of 2-CdA were more frequently observed
in previously treated patients. Hemorrhagic complications due to drug-
induced thrombocytopenia were noticed in 25 (22.7%) and severe infecti
ons including sepsis in 14 (12.7%) patients.